Skip to main content

Advertisement

SpringerLink
Log in

Effect of phenytoin on retinal ganglion cells in acute isolated optic neuritis

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Objective

Phenytoin has been shown to reduce the peripapillary retinal nerve fiber layer (pRNFL) loss in optic neuritis (ON). We evaluated the effects of phenytoin on retinal ganglion layers and visual outcomes of newly diagnosed acute ON.

Methods

A randomized, placebo-controlled trial was conducted in a tertiary referral eye hospital and patients with the first episode of typical demyelinating ON, without any history of multiple sclerosis were randomly assigned to phenytoin or placebo. The thickness of ganglion cell-inner plexiform layer (GCIPL) measured by optical coherence tomography (OCT) was considered as the primary outcome.

Results

One patient in the phenytoin group developed severe cutaneous rashes that progressed to Stevens-Johnson syndrome (SJS)/toxic epidermal necrosis (TEN), and further allocation of patients to the phenytoin group was stopped, and finally fifteen participants were included in the phenytoin group. Fifty-one patients were enrolled to the placebo group, from which four were excluded. Both visual acuity and field were not significantly different between the control and phenytoin groups after 1 and 6 months. Mean 3- and 6-mm macular GCIPL thicknesses decreased after 6 months to 73.6 ± 14.1 and 57.9 ± 7.5 μm, respectively, in the phenytoin group and to 71.6 ± 15.7 and 55.6 ± 6.6 μm, respectively, in the placebo group with no significant differences between the two groups (P = 0.77 and P = 0.26, respectively, linear multilevel model).

Conclusion

Phenytoin is not probably safe and effective as neuroprotection after acute ON. Further investigation with other sodium channel inhibitors could be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fard MA, Afzali M, Abdi P, Yasseri M, Ebrahimi KB, Moghimi S (2016) Comparison of the pattern of macular ganglion cell-inner plexiform layer defect between ischemic optic neuropathy and open-angle glaucoma. Invest Ophthalmol Vis Sci 57:1011–1016

    Article  Google Scholar 

  2. Akbari M, Abdi P, Fard MA, Afzali M, Ameri A, Yazdani-Abyaneh A, Mohammadi M, Moghimi S (2016) Retinal ganglion cell loss precedes retinal nerve fiber thinning in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 36:141–146

    Article  Google Scholar 

  3. Aghsaei Fard M, Okhravi S, Moghimi S, Subramanian PS (2019) Optic nerve head and macular optical coherence tomography measurements in papilledema compared with pseudopapilledema. J Neuroophthalmol 39:28–34

    Article  Google Scholar 

  4. Kallenbach K, Frederiksen J (2007) Optical coherence tomography in optic neuritis and multiple sclerosis: a review. Eur J Neurol 14:841–849

    Article  CAS  Google Scholar 

  5. Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ, ERN-EYE IMSVISUAL (2017) Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 16:797–812

    Article  Google Scholar 

  6. Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ (2014) Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler 20:1331–1341

    Article  Google Scholar 

  7. Henderson AP, Altmann DR, Trip AS, Kallis C, Jones SJ, Schlottmann PG, Garway-Heath DF, Plant GT, Miller DH (2010) A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 133:2592–2602

    Article  Google Scholar 

  8. Fard MA, Ebrahimi KB, Miller NR (2013) RhoA activity and postischemic inflammation in an experimental model of adult rodent anterior ischemic optic neuropathy. Brain Res 1534:76–86

    Article  CAS  Google Scholar 

  9. Garas A, Simó M, Holló G (2011) Nerve fiber layer and macular thinning measured with different imaging methods during the course of acute optic neuritis. Eur J Ophthalmol 21:473–483

    Article  Google Scholar 

  10. Beisse F, Diem R (2016) Immunomodulation and neuroprotection in optic neuritis. Ophthalmologe 113:398–401

    Article  CAS  Google Scholar 

  11. Hickman SJ, Kapoor R, Jones SJ et al (2003) Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psychiatry 74:1139–1141

    Article  CAS  Google Scholar 

  12. Esfahani MR, Harandi ZA, Movasat M et al (2012) Memantine for axonal loss of optic neuritis. Graefes Arch Clin Exp Ophthalmol 250:863–809

    Article  CAS  Google Scholar 

  13. Suhs KW, Hein K, Sattler MB et al (2012) A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol 72:199–210

    Article  Google Scholar 

  14. Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S, RENEW Study Investigators (2017) Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 16:189–199

    Article  CAS  Google Scholar 

  15. Chiosi F, Keppel Hesselink J et al (2018) Phenytoin: its potential as neuroprotective and retinoprotective drug. Br J Clin Pharmacol 84:195–196

    Article  Google Scholar 

  16. Bartollino S, Chiosi F, di Staso S et al (2018) The retinoprotective role of phenytoin. Drug Des Devel Ther 12:3485–3489

    Article  CAS  Google Scholar 

  17. Raftopoulos R, Hickman SJ, Toosy A, Sharrack B, Mallik S, Paling D, Altmann DR, Yiannakas MC, Malladi P, Sheridan R, Sarrigiannis PG, Hoggard N, Koltzenburg M, Gandini Wheeler-Kingshott CA, Schmierer K, Giovannoni G, Miller DH, Kapoor R (2016) Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15:259–269

    Article  CAS  Google Scholar 

  18. Gabilondo I, Martinez-Lapiscina EH, Fraga-Pumar E et al (2015) Dynamics of retinal injury after acute optic neuritis. Ann Neurol 77:517–528

    Article  Google Scholar 

  19. Britze J, Pihl-Jensen G, Frederiksen JL (2017) Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis. J Neurol 264:1837–1853

    Article  Google Scholar 

  20. Saidha S, Calabresi PA (2016) Phenytoin in acute optic neuritis: neuroprotective or not? Lancet Neurol 15:233–235

    Article  Google Scholar 

  21. Behbehani R, Al-Moosa A, Sriraman D et al (2016) Ganglion cell analysis in acute optic neuritis. Mult Scler Relat Disord 5:66–69

    Article  CAS  Google Scholar 

  22. Błaszczyk B, Lasoń W, Czuczwar SJ (2015) Antiepileptic drugs and adverse skin reactions: an update. Pharmacol Rep 67:426–434

    Article  Google Scholar 

  23. Harr T, French LE (2010) Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 5:39

    Article  Google Scholar 

  24. Yang CY, Dao RL, Lee TJ, Lu CW, Yang CH, Hung SI, Chung WH (2011) Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology 77:2025–2033

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Farabi Eye Hospital, Tehran University of Medical science, Qazvin Sq, Tehran, Iran

    Samira Yadegari, Alireza Gholizade, Hossein Ghahvehchian & Masoud Aghsaei Fard

Authors
  1. Samira Yadegari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alireza Gholizade
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hossein Ghahvehchian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masoud Aghsaei Fard
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Masoud Aghsaei Fard: Conceptualization; writing of original draft preparation

Alireza Gholizade: Data curation; formal analysis

Samira Yadeghari: Data curation; formal analysis

Hossein Ghahvehchian: Data curation; formal analysis

Corresponding author

Correspondence to Masoud Aghsaei Fard.

Ethics declarations

Conflict of interest

The Authors declares that they have no conflict of interest.

Ethical approval

The study was approved and monitored by the Tehran University of Medical Sciences Research and Ethics Committee.

Informed consent

Written consent was obtained from the patient for publication of their imaging and case description.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This trial is registered in ClinicalTrials.gov, number NCT02939937.

https://clinicaltrials.gov/ct2/show/study/NCT02939937?term=NCT02939937&draw=2&rank=1

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yadegari, S., Gholizade, A., Ghahvehchian, H. et al. Effect of phenytoin on retinal ganglion cells in acute isolated optic neuritis. Neurol Sci 41, 2477–2483 (2020). https://doi.org/10.1007/s10072-020-04360-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04360-2

Keywords

Search

Navigation